Methods and systems for coating a medical device
A coating system and method are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two of the cyclic groups may include quaternary ammonium moieties. In some embodiments, a method may include applying a coating to a surface of a medical device. The coating may be antimicrobial. A coating may include antimicrobial bridged polycyclic compounds. In some embodiments, bridged polycyclic compounds may include quaternary ammonium compounds. In some embodiments, bridged polycyclic compounds may include guanidinium moieties. Bridged polycyclic compounds based coating systems may impart self-cleaning properties to a surface.
1. A method of coating a medical device, comprising:
applying a composition to at least a portion of a surface of a medical device, the composition
comprising at least one bridged polycyclic compound, the at least one bridged polycyclic compound comprising at least two cyclic groups, wherein the at least one bridged polycyclic compound comprises a structure:
wherein each R 1 is independently an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, N, N + R 3 , a heterocycle group, or a substituted heterocycle group;
wherein each R 2 is independently an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group, a substituted heterocycle group, a covalent bond, or an alkene;
wherein each R 3 is independently an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group, a substituted heterocycle group, an alkene, an ether, a polyethylene glycol, a benzyl group, a hydrogen, a hydrophilic group, or a polyethyleneimine;
wherein each R 4 is independently an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group, a substituted heterocycle, an ether, an amide, an alcohol, an ester, a sulfonamide, a sulfanilamide, or an alkene;
wherein Z comprises at least one bridge, wherein at least one of the bridges is
—R 2 —N + R 3 2 —R 4 —N + R 3 2 —R 2 —, —R 2 —NR 3 —R 4 —N + R 3 2 —R 2 —, —R 2 —NR 3 —R 4 —NR 3 —R 2 —, or —R 2 —N═R 4 ═N—R 2 —, and wherein each bridge independently couples R 1 to R 1 ; and
wherein X comprises at least one negatively charged counter ion; and forming an antimicrobial coating over at least a portion of the surface.
2. The method of claim 1 , wherein at least one X is iodine.
3. The method of claim 1 , wherein at least one X is bromine.
4. The method of claim 1 , wherein at least one X is chlorine.
5. The method of claim 1 , wherein at least one R 3 comprises a guanidinium moiety.
6. The method of claim 1 , wherein at least one R 3 comprises a quaternary ammonium moiety.
7. The method of claim 1 , wherein each R 3 is independently an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group, a substituted heterocycle group, an alkene, an ether, a polyethyleneglycol, a benzyl group, a hydrogen, a hydrophilic group, or a polyethyleneimine, and wherein at least one alkyl group comprises a C5-C7 alkyl group.
8. The method of claim 1 , wherein at least one of the bridged polycyclic compound comprises a structure:
9. The method of claim 8 , wherein R 2 is —(CH 2 ) 2 —.
10. The method of claim 8 , wherein R 4 is a substituted aryl group, and wherein the substituted aryl group comprises —(CH 2 )-phenyl-(CH 2 )—.
11. The method of claim 8 , wherein at least one R 3 is a substituted aryl group.
12. The method of claim 8 , wherein at least one R 3 comprises a substituted aryl group, wherein at least one of the substituted aryl group's substituents comprises a guanidinium group.
13. The method of claim 8 , wherein at least one R 3 comprises a substituted aryl group, wherein at least one of the substituted aryl group's substituents is a halogen, and wherein at least one of the substituted aryl group's substituents comprises a guanidinium group.
14. The method of claim 1 , wherein at least one of the bridged polycyclic compounds comprises a structure (IV):
wherein at least one R 3 is a benzyl group, and wherein at least one R 3 is a C5-C7 alkyl group or a C5-C7 substituted alkyl group; and wherein at least one R 4 is an aryl group or a substituted aryl group.
15. The method of claim 1 , wherein at least one of the bridged polycyclic compounds comprises a structure (IVa):
wherein at least one R 3 is a benzyl group, wherein at least one R 3 is a C5-C7 alkyl group or a C5-C7 substituted alkyl group; wherein at least one R 4 is an aryl group or a substituted aryl group, and wherein M comprises one or more guest molecules associated with one or more portions of compound (IVa).
16. The method of claim 1 , wherein the medical device comprises at least a portion of a stent.
17. The method of claim 1 , wherein the medical device comprises at least a portion of a catheter.
18. The method of claim 1 , wherein the medical device comprises at least a portion of a cannula.
19. The method of claim 1 , wherein the medical device comprises at least a portion of a contact lens.
20. The method of claim 1 , wherein the medical device comprises at least a portion of a feeding tube.
21. The method of claim 1 , wherein the medical device comprises at least a portion of a dental device or at least a portion of a dental fixture.
22. The method of claim 1 , wherein the composition is included as part of an application kit for coating at least a portion of the medical device.
23. The method of claim 1 , wherein the composition further comprises a solvent.
24. The method of claim 1 , wherein the composition further comprises a solvent, and wherein the solvent comprises water.
25. The method of claim 1 , wherein the composition further comprises a solvent, and wherein the solvent comprises an alcohol based solvent.
26. The method of claim 1 , wherein the composition further comprises a solvent, and wherein the solvent comprises water and an alcohol based solvent.
27. The method of claim 1 , wherein the composition further comprises a solvent and a polymer, and wherein the solvent comprises water and an alcohol based solvent.
28. The method of claim 1 , wherein the composition further comprises a polymer and/or a polymerizable compound.
29. A method of coating a medical device, comprising:
applying a composition to at least a portion of a surface of a medical device, the composition comprising at least one bridged polycyclic compound, the at least one bridged polycyclic compound comprising at least two cyclic groups, wherein at least one of the cyclic groups comprises a guanidinium moiety coupled to the cyclic group; and forming an antimicrobial coating over at least a portion of the surface.
30. The method of claim 29 , wherein at least one of the bridged polycyclic compounds comprises at least four quaternary ammonium moieties which define at least two of the cyclic groups forming the bridged polycyclic compounds.
31. The method of claim 29 , wherein the medical device comprises at least a portion of a stent.
32. The method of claim 29 , wherein the medical device comprises at least a portion of a catheter.
33. The method of claim 29 , wherein the medical device comprises at least a portion of a cannula.
34. The method of claim 29 , wherein the medical device comprises at least a portion of a contact lens.
35. The method of claim 29 , wherein the medical device comprises at least a portion of a feeding tube.
36. The method of claim 29 , wherein the composition is included as part of an application kit for coating at least a portion of the medical device.
37. The method of claim 29 , wherein at least one of the cyclic groups comprises an amide moiety coupled to the cyclic group.
38. The method of claim 29 , wherein at least one of the bridged polycyclic compounds comprises a structure:
wherein each R 1 is independently N, N + H, or N + R 3 ;
wherein at least one R 3 comprises a substituted aryl group, wherein at least one of the substituted aryl group's substituents is a halogen, and wherein at least one of the substituted aryl group's substituents comprises a guanidinium moiety; and
wherein X comprises at least one negatively charged counter ion.
39. The method of claim 29 , wherein the composition further comprises a solvent.
40. The method of claim 29 , wherein the composition further comprises a solvent, and wherein the solvent comprises water.
41. The method of claim 29 , wherein the composition further comprises a solvent, and wherein the solvent comprises an alcohol based solvent.
42. The method of claim 29 , wherein the composition further comprises a solvent, and wherein the solvent comprises water and an alcohol based solvent.
43. The method of claim 29 , wherein the composition further comprises a solvent and a polymer, and wherein the solvent comprises water and an alcohol based solvent.
44. The method of claim 29 , wherein the composition further comprises a polymer and/or a polymerizable compound.
45. The method of claim 29 , wherein the medical device comprises at least a portion of a dental device or at least a portion of a dental fixture.